Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patients.

Atevirdine mesylate (U-87201E) is a new nonnucleoside (bisheteroarylpiperazine) inhibitor of human immunodeficiency virus type 1 reverse transcriptase. In a double-blind, escalating single-dose study the safety, tolerance, and pharmacokinetics of atevirdine mesylate were investigated in 24 asymptoma...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Been-Tiktak, A M, Vrehen, H M, Schneider, M M, van der Feltz, M, Branger, T, Ward, P, Cox, S R, Harry, J D, Borleffs, J C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1995
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC162591/
https://ncbi.nlm.nih.gov/pubmed/7793859
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia